Dr Bal Matharu
Bal specialises in the pharmaceutical field and has considerable experience in securing and defending patent rights, conducting IP due diligence evaluations for licensing/acquisition deals and providing advice in relation to infringement queries. Bal also has extensive experience of co-ordinating multi-jurisdictional patent litigation across Europe and beyond. Bal joined the Manchester HGF office in October 2015.
Bal has a strong technical background and has spent over 6 years working as a senior product development scientist within the pharmaceutical industry. Bal has also spent over 9 years working within the in-house patent department of a major global pharmaceutical company.
After gaining a first class Bachelor of Pharmacy degree and a PhD in the pulmonary delivery of peptide and protein drugs, both from King’s College London, Bal joined a drug delivery company to work on a range of specialised oral and transdermal formulation technologies.
In May 2002, Bal moved to a global pharmaceutical company, where he was responsible for leading technical programs to develop complex dosage forms. Part of his role involved building networks with universities and drug delivery companies to seek opportunities of applying new technologies to existing medicines. Bal is an inventor on two injectable formulation patents for a particular oncology medicine.
In 2006, Bal transitioned into the in-house IP department of the pharmaceutical company, where he went on to qualify as a UK and European Patent Attorney.
During his patent career, he has been responsible for managing patent portfolios for a number of high priority drug development projects and marketed products. Bal has also provided extensive support for business development activities and has worked on numerous due diligence evaluations, ranging from early stage collaboration agreements to major global out-sourcing collaborations and late-stage product and company acquisitions.
During the last 3 years, Bal has led a multi-disciplinary patent and regulatory litigation team to defend a major product in multiple jurisdictions across Europe, South America and Asia. Activities have included defending revocation and non-infringement actions, filing and securing injunctions, co-ordinating main infringement/damages actions and negotiating patent settlement agreements. Bal has developed a deep knowledge of the strategic and country-specific aspects of pharmaceutical patent litigation through working closely with a wide network of IP litigation counsel.
Bal is able to draw on his broad technical, patent and industry experience to provide clients with pragmatic business advice in relation to a range of exclusivity matters, including patent portfolio management, enforcing patent rights, challenging third party patent rights and conducting IP due diligence evaluations to support licensing and acquisition deals.